Literature DB >> 22577976

Disruption of actin cytoskeleton enhanced cytokine synthesis of splenocytes stimulated with beta-glucan from the cauliflower medicinal mushroom, Sparassis crispa Wulf.:Fr. (higher Basidiomycetes) in vitro.

Asami Shibata1, Toshie H Hida, Ken-Ichi Ishibashi, Noriko N Miura, Yoshiyuki Adachi, Naohito Ohno.   

Abstract

Beta-glucan (BG) is a representative pathogen-associated molecular pattern (PAMP) produced by pathogenic fungi. SCG is a BG obtained from Sparassis crispa, which stimulates splenocytes in DBA/2 mice to produce cytokines, such as GM-CSF, IFN-γ, and TNF-α. In the present study, we analyzed the molecular mechanism of SCG-mediated cytokine synthesis using cytocharasin D (CytD), an inhibitor of actin polymerization. It was found that GM-CSF and TNF-α synthesis of splenocytes stimulated with SCG, but not with lipopolysaccharide, was significantly enhanced in the presence of CytD. CRDO, partially hydrolyzed linear 1,3-BG curdlan, stimulated splenocytes of DBA/2 mice slightly to produce cytokines. CRDO, acting as an antagonist in the presence of SCG, changed to a strong agonist in the presence of CytD. CytD also enhanced cytokine synthesis of bone marrow-derived dendritic cells. Taken together, cytokine productivity of BG was significantly dependent on molecular weight, and CytD treatment is useful to enhance the sensitivity for analyzing the immunostimulating activity of BG in vitro.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22577976     DOI: 10.1615/intjmedmushr.v14.i3.30

Source DB:  PubMed          Journal:  Int J Med Mushrooms        ISSN: 1940-4344            Impact factor:   1.921


  2 in total

1.  Sparassis crispa Intake Improves the Reduced Lipopolysaccharide-Induced TNF-α Production That Occurs upon Exhaustive Exercise in Mice.

Authors:  Masataka Uchida; Naoki Horii; Natsuki Hasegawa; Eri Oyanagi; Hiromi Yano; Motoyuki Iemitsu
Journal:  Nutrients       Date:  2019-09-02       Impact factor: 5.717

Review 2.  Natural products and biological activity of the pharmacologically active cauliflower mushroom Sparassis crispa.

Authors:  Takashi Kimura
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.